In rectal cancer, serine protease inhibitor Kazal type 1 (SPINK1) enhances the proliferation and migration of cancer cells by activating epidermal growth factor receptor-downstream ERK, p38, and JNK signaling pathways. The gene discussed is MAPK8; the disease is cancer.